Serum levels of bone resorption markers are decreased in patients with type 2 diabetes

Acta Diabetologica

Volumn 50, Issue 1, 2013, Pages 47-52

  Reyes García, Rebeca ^a   Rozas Moreno, Pedro ^a,b   López Gallardo, Gema ^b   García Martín, Antonia ^a   Varsavsky, Mariela ^a   Avilés Perez, Maria Dolores ^a   Muñoz Torres, Manuel ^a  

^a HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE CIUDAD REAL   (Spain)

Author keywords

Bone turnover markers; i PTH; Type 2 diabetes

Indexed keywords

25 HYDROXYVITAMIN D; ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME 5B; ALKALINE PHOSPHATASE BONE ISOENZYME; CARBOXY TERMINAL TELOPEPTIDE; OSTEOCALCIN; PARATHYROID HORMONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD SAMPLING; BONE DENSITY; BONE TURNOVER; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE DURATION; DUAL ENERGY X RAY ABSORPTIOMETRY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FRACTURE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OSSIFICATION; OSTEOLYSIS; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RISK ASSESSMENT;

ADULT; AGED; BIOLOGICAL MARKERS; BONE DENSITY; BONE RESORPTION; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; PARATHYROID HORMONE;

EID: 84873099232     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-011-0347-0     Document Type: Article

References (23)

1. Janghorbani M, Van Dam RM, Willet WC, Hu FB (2007) Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol 166:495-505
2. Majima T, Komatsu Y, Yamada T, Koike Y, Shigemoto M, Takagi C, Hatanaka I, Nakao K (2005) Decreased bone mineral density at the distal radius, but not al the lumbar spine or the femoral neck, in Japanese type 2 diabetic patients. Osteoporos Int 16:907-913
3. Bridges MJ, Moochala SH, Barbour J, Kelly CA (2005) Influence of diabetes on peripheral bone mineral density in men: a controlled study. Acta Diabetol 42:82-86
4. Dobnig H, Piswanger-Solkner JC, Roth M, Obermayer-Pietsch B, Tiran A, Strele A, Maier E, Maritschnegg P, Sieberer C, Fahrleitner-Pammer A (2006) Type 2 diabetes mellitus in nursing home patients: effects on bone turnover bone mass, and fracture risk. J Clin Endocrinol Metab 91:3355-3363
5. Schwartz AV, Sellmeyer DE, Ensrud KE, Cauley JA, Tabor HK, Schreiner PJ, Jamal SA, Black DM, Cummings SR (2001) Older women with diabetes have an increased risk of fracture: a prospective study. J Clin Endocrinol Metab 86:32-38
6. Vestegaard P, Rejnmark L, Mosekilde L (2005) Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk. Diabetolologia 48:1292-1299
7. Yamamoto M, Yamaguchi T, Yamauchi M, Kaji H, Sugimoto T (2009) Diabetic patients have an increased risk of vertebral fractures independent of BMD or diabetic complications. J Bone Miner Res 24:702-709
8. Gerdhem P, Isaksson A, Akesson K, Obrant KJ (2005) Increased bone density and decreased bone turnover, but no evident alteration of fracture susceptibility in elderly women with diabetes mellitus. Osteoporos Int 16:1506-1512
9. Hernandez CJ, Tang SY, Baumbach BM, Hwu PB, Sakkee AN, van der Ham F, DeGroot J, Bank RA, Keaveny TM (2005) Trabecular microfracture and the influence of piridinum and non-enzymatic glycation-mediated collagen crosslinks. Bone 37:825-832
10. De Liefde II, van der Klift M, de Laet C, van Daele PL, Hofman A, Pols HA (2005) Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam study. Osteoporos Int 16:1713-1720
11. Vasilkova O, Mokhort T, Sharshakova T, Hayashida N, Takamura N (2011) Leptin is an independent determinant of bone mineral density in men with type 2 diabetes mellitus. Acta Diabetol Feb 16. [Epub ahead of print]
12. Li YM, Schilling T, Benisch P, Zeck S, Meissner-Weigl J, Schneider D, Limbert C, Seufert J, Kassem M, Schütze N, Jakob F, Ebert R (2007) Effects of high glucose on mesenchymal stem cell proliferation and differentiation. Biochem Biophys Res Commun 363:209-215
13. Wittrant Y, Gorin Y, Woodruff K, Horn D, Abboud HE, Mohan S, Abboud-Werner S (2008) High d(+)glucose concentration inhibits RANKL-induced osteoclastogenesis. Bone 42:1122-1130
14. Rosato MT, Schneider SH, Shapses SA (1998) Bone turnover and insulin-like growth factor I levels increase after improved glycemic control in noninsulin-dependent diabetes mellitus. Calcif Tissue Int 63:107-111
15. Takizawa M, Suzuki K, Matsubayashi T, Kikuyama M, Suzuki H, Takahashi K, Katsuta H, Mitsuhashi J, Nishida S, Yamaguchi S, Yoshimoto K, Itagaki E, Ishida H (2008) Increased bone resorption may play a crucial role in the occurrence of osteopenia in patients with type 2 diabetes: possible involvement of accelerated polyol pathway in its pathogenesis. Diabetes Res Clin Pract 82:119-126
16. Oz SG, Guven GS, Kilicarslan A, Calik N, Beyazit Y, Sozen T (2006) Evaluation of bone metabolism and bone mass in patients with type-2 diabetes mellitus. J Natl Med Assoc 98:1598-1604
17. Achemlal L, Tellal S, Rkiouak F, Nouijai A, Bezza A, Derouiche ELM, Ghafir D, El Maghraoui A (2005) Bone metabolism in male patients with type 2 diabetes. Clin Rheumatol 24:493-496
18. Suzuki K, Kurose T, Takizawa M, Maruyama M, Ushikawa K, Kikuyama M, Sugimoto C, Seino Y, Nagamatsu S, Ishida H (2005) Osteoclastic function is accelerated in male patients with type 2 diabetes mellitus: the preventive role of osteoclastogenesis inhibitory factor/osteoprotegerin (OCIF/OPG) on the decrease of bone mineral density. Diabetes Res Clin Pract 68:117-125
19. Finkelstein JS, Sowers M, Greendale GA, Lee ML, Neer RM, Cauley JA, Ettinger B (2002) Ethnic variation in bone turnover in pre- and early perimenopausal women: effects of anthropometric and lifestyle factors. J Clin Endocrinol Metab 87:3051-3056
20. Capoglu I, Ozkan A, Ozkan B, Umudum Z (2008) Bone turnover markers in patients with type 2 diabetes and their correlation with glycosylated haemoglobin levels. J Int Med Res 36:1392-1398
21. Inaba M, Okuno S, Nagasue K, Otoshi T, Kurioka Y, Maekawa K, Kumeda Y, Imanishi Y, Ishimura E, Ohta T, Morii H, Kim M, Nishizawa Y (2001) Impaired secretion of parathyroid hormone is coherent to diabetic hemodialyzed patients. Am J Kidney Dis 38:S139-S142
22. Tsuchida T, Sato K, Miyañoshi N, Abe T, Kudo T, Tamura Y, Kasukawa Y, Suzuki K (2000) Histomorphometric evaluation of the recovering effect on human parathyroid hormone (1-34) on bone structure and turnover in streptozotocin-induced diabetic rats. Calcif Tissue Int 66:229-233
23. Pedrazzoni M, Ciotti G, Pioli G, Girasole G, Davoli L, Palummeri E, Passeri M (1989) Osteocalcin levels in diabetic subjects. Calcif Tissue Int 45:331-336